» Articles » PMID: 21677747

Genetics and Pathogenesis of Inflammatory Bowel Disease

Overview
Journal Nature
Specialty Science
Date 2011 Jun 17
PMID 21677747
Citations 1141
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advances have provided substantial insight into the maintenance of mucosal immunity and the pathogenesis of inflammatory bowel disease. Cellular programs responsible for intestinal homeostasis use diverse intracellular and intercellular networks to promote immune tolerance, inflammation or epithelial restitution. Complex interfaces integrate local host and microbial signals to activate appropriate effector programs selectively and even drive plasticity between these programs. In addition, genetic studies and mouse models have emphasized the role of genetic predispositions and how they affect interactions with microbial and environmental factors, leading to pro-colitogenic perturbations of the host-commensal relationship.

Citing Articles

Gut microbiota therapy in gastrointestinal diseases.

Ullah H, Arbab S, Chang C, Bibi S, Muhammad N, Rehman S Front Cell Dev Biol. 2025; 13:1514636.

PMID: 40078367 PMC: 11897527. DOI: 10.3389/fcell.2025.1514636.


Fecal Microbiota Transplantation (FMT) and Clinical Outcomes Among Inflammatory Bowel Disease (IBD) Patients: An Umbrella Review.

Malik S, Naqvi S, Shadali A, Khan H, Christof M, Niu C Dig Dis Sci. 2025; .

PMID: 40038211 DOI: 10.1007/s10620-025-08946-8.


Sodium butyrate alleviates DSS-induced inflammatory bowel disease by inhibiting ferroptosis and modulating ERK/STAT3 signaling and intestinal flora.

Liu Y, Chen N, He H, Liu L, Sun S Ann Med. 2025; 57(1):2470958.

PMID: 40028886 PMC: 11878173. DOI: 10.1080/07853890.2025.2470958.


Pathological characteristics of inflammatory bowel diseases.

Nakajima M, Iwao Y, Okabayashi K, Kanai Y, Shimoda M J Med Ultrason (2001). 2025; .

PMID: 40025407 DOI: 10.1007/s10396-025-01520-9.


Orally Administrated Inulin-Modified Nanozymes for CT-Guided IBD Theranostics.

Li X, Cao L, Li J, Li Z, Ma H, Cheng S Int J Nanomedicine. 2025; 20:2119-2131.

PMID: 39990289 PMC: 11846537. DOI: 10.2147/IJN.S497558.


References
1.
Yu R, Gallagher G . A naturally occurring, soluble antagonist of human IL-23 inhibits the development and in vitro function of human Th17 cells. J Immunol. 2010; 185(12):7302-8. DOI: 10.4049/jimmunol.1002410. View

2.
Janse M, Lamberts L, Franke L, Raychaudhuri S, Ellinghaus E, Boberg K . Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology. 2011; 53(6):1977-85. PMC: 3121050. DOI: 10.1002/hep.24307. View

3.
Dolowschiak T, Chassin C, Ben Mkaddem S, Fuchs T, Weiss S, Vandewalle A . Potentiation of epithelial innate host responses by intercellular communication. PLoS Pathog. 2010; 6(11):e1001194. PMC: 2987820. DOI: 10.1371/journal.ppat.1001194. View

4.
Fuhrer A, Sprenger N, Kurakevich E, Borsig L, Chassard C, Hennet T . Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. J Exp Med. 2010; 207(13):2843-54. PMC: 3005226. DOI: 10.1084/jem.20101098. View

5.
Biswas A, Liu Y, Hao L, Mizoguchi A, Salzman N, Bevins C . Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A. 2010; 107(33):14739-44. PMC: 2930434. DOI: 10.1073/pnas.1003363107. View